Position in MDXG
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$504,537
+$311,865 QoQ
Shares Held
131,049
+168.7% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 226 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. MDXG ranks #201 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in MDXG
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $504,537 | 131,049 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $192,672 | 48,778 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,643,379 | 390,455 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,445,752 | 493,661 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $3,833,441 | 627,405 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,235,160 | 557,258 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $6,667,678 | 693,106 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,757,438 | 297,367 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $563,906 | 81,372 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $764,955 | 99,345 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $669,642 | 76,356 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $577,994 | 79,286 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $598,706 | 90,576 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $307,802 | 90,265 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $191,692 | 69,134 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $185,478 | 64,627 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $219,680 | 63,309 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $368,405 | 78,218 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $404,739 | 67,010 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $520,619 | 85,911 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $854,081 | 68,272 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $30,900 | 3,000 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $114,108 | 12,567 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||